Zurzuvae (zuranolone)
Pharmacy benefit prior authorization and quantity limit policy for Zurzuvae (zuranolone) for treatment of postpartum depression in adults, including initial and continuation criteria, quantity limits, and approval durations. Applies to Commercial/Exchange plans; excludes MassHealth UPPL.
Updated language for members who are new to the Plan; updated verbiage for specialist prescriber and changed 'medical records' to 'documentation.'
Policy originally created and reviewed at Feb P&T, effective 03/01/2024.